Transforming pre-analytical sample processing for the next generation of blood-based molecular diagnostics
Transforming pre-analytical sample processing for the next generation of blood-based molecular diagnostics
To redefine how diagnostic insights are generated by transforming the earliest stages of sample processing.
We are committed to developing technologies that make advanced molecular testing more accessible and impactful across global healthcare.
AG10 Bio Ltd is an early stage biotechnology startup company focused on advancing innovation in precision medicine.
Based at the Precision Health Technology Accellerator, which is part of the University of Birmingham’s flagship Birmingham Health Innovation Campus, we are developing a next-generation platform designed to improve pre-analytical sample processing and enhance blood-based diagnostics workflows.
AG10 Bio Ltd develops practical, high-performance diagnostic solutions that enhance operational efficiency, reduce healthcare costs, and improve patient outcomes. We are building a scalable organisation committed to sustainable, long-term value in the diagnostics sector
We will be actively seeking strategic partnerships with academic institutions, clinical researchers, and industry leaders who share our vision for the future of healthcare innovation.
